Intermediate Risk Non-Muscle Invasive Bladder Cancer
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB17381 | Nadofaragene firadenovec | 3 | Not Yet Recruiting | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB17381 | Nadofaragene firadenovec | 3 | Not Yet Recruiting | 1 |